Found: 17
Select item for more details and to access through your institution.
Safety of Amlodipine in Early Pregnancy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lemborexant levels in maternal serum, cord blood, and breast milk during pregnancy and lactation: A case report.
- Published in:
- Psychiatry & Clinical Neurosciences Reports, 2023, v. 2, n. 1, p. 1, doi. 10.1002/pcn5.62
- By:
- Publication type:
- Article
Eplerenone levels in maternal serum, cord blood, and breast milk during pregnancy and lactation.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00249-8
- By:
- Publication type:
- Article
Transfer of brotizolam, periciazine, and sulpiride in cord blood and breast milk, and alprazolam in breast milk: a case report.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00241-2
- By:
- Publication type:
- Article
Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi‐institutional study.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 1, p. 146, doi. 10.1111/bcp.15876
- By:
- Publication type:
- Article
Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 6, p. 1130, doi. 10.1111/1756-185X.13557
- By:
- Publication type:
- Article
Pregnancy outcomes after first‐trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions.
- Published in:
- Congenital Anomalies, 2024, v. 64, n. 5, p. 199, doi. 10.1111/cga.12577
- By:
- Publication type:
- Article
Risk of major birth defects after first‐trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy.
- Published in:
- Congenital Anomalies, 2024, v. 64, n. 3, p. 91, doi. 10.1111/cga.12557
- By:
- Publication type:
- Article
Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in Pregnancy.
- Published in:
- Congenital Anomalies, 2024, v. 64, n. 1, p. 6, doi. 10.1111/cga.12547
- By:
- Publication type:
- Article
The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two‐centered cohort study in Japan.
- Published in:
- Congenital Anomalies, 2022, v. 62, n. 4, p. 161, doi. 10.1111/cga.12471
- By:
- Publication type:
- Article
Pravastatin concentrations in maternal serum, umbilical cord serum, breast milk and neonatal serum during pregnancy and lactation: A case study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 703, doi. 10.1111/jcpt.13590
- By:
- Publication type:
- Article
Abatacept concentrations in maternal serum and breast milk during breastfeeding and an infant safety assessment: a case study.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
- Published in:
- Rheumatology, 2019, v. 58, n. 8, p. 1505, doi. 10.1093/rheumatology/kez100
- By:
- Publication type:
- Article
Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Etizolam levels in maternal serum, cord blood, and breast milk during pregnancy and lactation: A case report.
- Published in:
- Psychiatry & Clinical Neurosciences, 2021, v. 75, n. 6, p. 211, doi. 10.1111/pcn.13216
- By:
- Publication type:
- Article
Tocilizumab drug levels during pregnancy and lactation: A woman who discontinued tocilizumab therapy until the end of the first trimester and resumed it after birth.
- Published in:
- Obstetric Medicine (1753-495X), 2021, v. 14, n. 4, p. 260, doi. 10.1177/1753495X20966094
- By:
- Publication type:
- Article